MorphoSys AG

NASDAQ: MOR · Real-Time Price · USD
18.96
0.45 (2.43%)
At close: Aug 02, 2024, 10:00 PM

MorphoSys Balance Sheet Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
158.5M 402.35M 123.25M
Short-Term Investments
524.26M 504.82M 870.42M
Long-Term Investments
3.55M 5.35M 9.19M
Other Long-Term Assets
1.22M 8.73M 4.06M
Receivables
42.65M 112.35M 85.79M
Inventory
62.07M 24.25M 20.76M
Other Current Assets
24.00 -367 15.94M
Total Current Assets
814.02M 1.09B 1.13B
Property-Plant & Equipment
14.99M 50.99M 49.59M
Goodwill & Intangibles
1.19B 1.24B 1.17B
Total Long-Term Assets
1.21B 1.31B 1.42B
Total Assets
2.03B 2.4B 2.56B
Account Payables
28.39M 38.58M 73.79M
Deferred Revenue
19.44M n/a 223.86K
Short-Term Debt
14.05M 9.59M 3.66M
Other Current Liabilities
202.43M 230.18M 206.87M
Total Current Liabilities
264.31M 278.35M 284.54M
Long-Term Debt
621.88M 329.87M 322.13M
Other Long-Term Liabilities
1.06B 1.62B 1.68B
Total Long-Term Liabilities
1.71B 1.96B 2.03B
Total Liabilities
1.98B 2.24B 2.31B
Total Debt
635.93M 339.46M 325.79M
Common Stock
37.66M 34.23M 34.23M
Retained Earnings
-1.01B -823.41M -672.35M
Comprehensive Income
88.44M 115.33M 52.76M
Shareholders Equity
49.05M 157.41M 244.88M
Total Investments
527.81M 510.18M 870.42M